USANA Health Sciences, Inc.
NYSE:USNAPackaged Foods
+$0.71 today
- Market cap
- $244.42M
- Beta
- 0.77
- P/E (TTM)
- 39.6
- EPS (TTM)
- $0.48
Volume 0.15M
Average 0.12M
USNA Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
USANA Health Sciences, Inc.NYSE: USNA
Depreciation & Amortization · Q1 FY2026 · quarter ended Apr 2026
Depreciation & amortization dips below year-ago levels
Q1 FY2026 depreciation & amortization of $9.79M fell 4.5% year over year, behind the +43.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 4.8% from the prior quarter. Over 3 fiscal years it compounded at +22.9% a year.
Context
- Depreciation & amortization amounted to 4.3% of revenue in FY2025, up 1.7 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -4.5% toward the trailing-twelve-month pace of +43.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 39.7M USD
- Year-over-year change
- +78.6%
- 4-year CAGR
- +15.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 39.7M | +78.6% |
| FY2024 | 2024-12-28 | 22.23M | +9.0% |
| FY2023 | 2023-12-31 | 20.4M | -4.7% |
| FY2022 | 2022-12-31 | 21.41M | -3.5% |
| FY2021 | 2021-12-31 | 22.19M | — |
Depreciation & Amortization vs competitors
How USNA compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +43.3% is the 3rd highest of 8, against a peer median of +3.6%.
- Depreciation & amortization amounts to 4.2% of revenue for USNA, versus a peer median of 3.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $74.4M USD | -15.1% | -3.9% | 4.1% | |
WESTWestrock Coffee Company, LLC | LTM Mar 2026 | $60.65M USD | +55.7% | +32.1% | 4.7% |
| LTM Apr 2026 | $39.25M USD | +43.3% | +22.9% | 4.2% | |
| LTM Mar 2026 | R$28.13M BRL | -75.1% | -45.9% | 5.2% | |
| LTM Mar 2026 | $11.78M USD | +3.6% | +49.5% | 2.8% | |
| LTM Apr 2026 | $5.7M USD | +138.8% | +52.8% | 3.0% | |
| LTM Mar 2026 | $4.1M USD | +16.2% | +10.2% | 1.8% | |
| LTM Mar 2026 | CN¥0 CNY | -100.0% | -21.8% | 0.0% | |
| Peer median (excluding USNA) | — | +3.6% | +10.2% | 3.0% | |
Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.19B | 998.6M | 921.01M | 854.5M | 925.26M |
| Cost of Revenue | 230.93M | 207.28M | 189.4M | 175.75M | 200.85M |
| Gross Profit | 955.53M | 791.32M | 731.62M | 678.75M | 724.41M |
| Gross Margin | 80.5% | 79.2% | 79.4% | 79.4% | 78.3% |
| Research & Development | 11.11M | 11.56M | 11.45M | 11.57M | 0 |
| Selling, General & Admin | 774.23M | 672.14M | 627.1M | 600.86M | 337.37M |
| Operating Expenses | 785.34M | 683.7M | 638.54M | 612.43M | 673.54M |
| Depreciation & Amortization | 22.19M | 21.41M | 20.4M | 22.23M | 39.7M |
| EBITDA | 192.89M | 130.22M | 123.11M | 98.86M | 82.07M |
| EBITDA Margin | 16.3% | 13.0% | 13.4% | 11.6% | 8.9% |
| Operating Income | 170.19M | 107.61M | 93.07M | 66.32M | 50.86M |
| Operating Margin | 14.3% | 10.8% | 10.1% | 7.8% | 5.5% |
| Interest Income | 2.52M | 3.79M | 9.64M | 11.32M | 2.42M |
| Interest Expense | 57K | 192K | 262K | 281K | 842K |
| Other Income / Expenses | 450K | 1.01M | 9.38M | 10.03M | (9.34M) |
| Income Before Tax | 170.64M | 108.62M | 102.45M | 76.35M | 41.53M |
| Pre-Tax Margin | 14.4% | 10.9% | 11.1% | 8.9% | 4.5% |
| Income Tax Expense | 54.14M | 39.27M | 38.67M | 34.29M | 30.05M |
| Net Income | 116.51M | 69.35M | 63.79M | 42.03M | 10.76M |
| Net Margin | 9.8% | 6.9% | 6.9% | 4.9% | 1.2% |
| EPS (Basic) | 5.78 | 3.60 | 3.33 | 2.20 | 0.58 |
| EPS (Diluted) | 5.73 | 3.59 | 3.30 | 2.19 | 0.58 |
| Weighted Avg Shares | 20.15M | 19.25M | 19.25M | 19.06M | 18.57M |
| Weighted Avg Shares (Diluted) | 20.34M | 19.31M | 19.35M | 19.16M | 18.57M |
USANA Health Sciences, Inc.
NYSE:USNA
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.